TSACC
gene geneOn this page
Also known as SSTK-IPSIP
Summary
TSACC (TSSK6 activating cochaperone, HGNC:30636) is a protein-coding gene on chromosome 1q22, encoding TSSK6-activating co-chaperone protein (Q96A04). Co-chaperone that facilitates HSP-mediated activation of TSSK6.
Enables protein-folding chaperone binding activity. Predicted to be active in cytoplasm.
Source: NCBI Gene 128229 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 24 total
- MANE Select transcript:
NM_001304817
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30636 |
| Approved symbol | TSACC |
| Name | TSSK6 activating cochaperone |
| Location | 1q22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SSTK-IP, SIP |
| Ensembl gene | ENSG00000163467 |
| Ensembl biotype | protein_coding |
| OMIM | 619679 |
| Entrez | 128229 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 protein_coding
ENST00000368251, ENST00000368252, ENST00000368253, ENST00000368254, ENST00000368255, ENST00000466306, ENST00000470342, ENST00000481479, ENST00000902464, ENST00000922497, ENST00000922498
RefSeq mRNA: 11 — MANE Select: NM_001304817
NM_001304817, NM_001304818, NM_001304819, NM_001304820, NM_001304821, NM_001304822, NM_001304823, NM_001304824, NM_001304825, NM_001304826, NM_144627
CCDS: CCDS1141, CCDS76223
Canonical transcript exons
ENST00000368254 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001446696 | 156338526 | 156338605 |
| ENSE00001446697 | 156346768 | 156346995 |
| ENSE00003710024 | 156344580 | 156344708 |
| ENSE00003710997 | 156339634 | 156339791 |
Expression profiles
Bgee: expression breadth ubiquitous, 160 present calls, max score 99.64.
FANTOM5 (CAGE): breadth broad, TPM avg 4.0558 / max 2791.3139, expressed in 692 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 5716 | 3.8980 | 670 |
| 5717 | 0.0564 | 10 |
| 5719 | 0.0452 | 4 |
| 5714 | 0.0180 | 4 |
| 5715 | 0.0176 | 4 |
| 5722 | 0.0089 | 1 |
| 5713 | 0.0048 | 4 |
| 5721 | 0.0040 | 2 |
| 5720 | 0.0029 | 2 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 99.64 | gold quality |
| right testis | UBERON:0004534 | 99.62 | gold quality |
| left testis | UBERON:0004533 | 99.48 | gold quality |
| adult organism | UBERON:0007023 | 99.13 | gold quality |
| testis | UBERON:0000473 | 97.03 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.30 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.64 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 80.90 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 80.61 | gold quality |
| kidney epithelium | UBERON:0004819 | 75.96 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 74.93 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 74.14 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 72.44 | gold quality |
| superficial temporal artery | UBERON:0001614 | 72.14 | gold quality |
| upper arm skin | UBERON:0004263 | 69.80 | gold quality |
| right adrenal gland | UBERON:0001233 | 69.33 | gold quality |
| deltoid | UBERON:0001476 | 69.27 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 68.07 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 67.70 | gold quality |
| left adrenal gland | UBERON:0001234 | 67.69 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 67.58 | gold quality |
| right lobe of liver | UBERON:0001114 | 66.82 | gold quality |
| cauda epididymis | UBERON:0004360 | 66.57 | gold quality |
| adrenal cortex | UBERON:0001235 | 66.44 | gold quality |
| tibialis anterior | UBERON:0001385 | 66.31 | silver quality |
| adrenal gland | UBERON:0002369 | 65.71 | gold quality |
| quadriceps femoris | UBERON:0001377 | 65.57 | gold quality |
| adrenal tissue | UBERON:0018303 | 64.43 | gold quality |
| gingival epithelium | UBERON:0001949 | 64.41 | gold quality |
| myocardium | UBERON:0002349 | 64.37 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 5800.81 |
| E-GEOD-124263 | yes | 2249.98 |
| E-ANND-3 | no | 2.54 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tsacc | ENSMUSG00000010538 |
| rattus_norvegicus | Tsacc | ENSRNOG00000037552 |
Protein
Protein identifiers
TSSK6-activating co-chaperone protein — Q96A04 (reviewed: Q96A04)
Alternative names: SSTK-interacting protein
All UniProt accessions (2): Q96A04, V9GYT6
UniProt curated annotations — full annotation on UniProt →
Function. Co-chaperone that facilitates HSP-mediated activation of TSSK6.
Subunit / interactions. Interacts with HSP70. Associates with HSP90. Interacts with TSSK6; this interaction is direct and recruits TSACC to HSP90.
Tissue specificity. Expressed in testis but is absent from mature sperm.
Similarity. Belongs to the TSACC family.
RefSeq proteins (11): NP_001291746, NP_001291747, NP_001291748, NP_001291749, NP_001291750, NP_001291751, NP_001291752, NP_001291753, NP_001291754, NP_001291755, NP_653228 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031679 | SSTK-IP | Family |
Pfam: PF15836
UniProt features (6 total): region of interest 2, compositionally biased region 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96A04-F1 | 67.99 | 0.23 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 58 (showing top):
TGCGCANK_UNKNOWN, chr1q22, GOMF_PROTEIN_FOLDING_CHAPERONE_BINDING, HSF2_01, HSF1_01, KOYAMA_SEMA3B_TARGETS_DN, NRF1_Q6, ASH1L_TARGET_GENES, BARX1_TARGET_GENES, FOXE1_TARGET_GENES, FOXG1_TARGET_GENES, ID2_TARGET_GENES, PITX1_TARGET_GENES, PPARGC1A_TARGET_GENES, PRKDC_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (2): protein-folding chaperone binding (GO:0051087), protein binding (GO:0005515)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
294 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TSACC | C22orf23 | Q9BZE7 | 661 |
| TSACC | CATSPERG | Q6ZRH7 | 587 |
| TSACC | ODAD4 | Q96NG3 | 580 |
| TSACC | CATSPERT | Q53TS8 | 569 |
| TSACC | ARMH4 | Q86TY3 | 547 |
| TSACC | GKAP1 | Q5VSY0 | 522 |
| TSACC | ACTRT2 | Q8TDY3 | 507 |
| TSACC | TSSK6 | Q9BXA6 | 507 |
| TSACC | SPATA16 | Q9BXB7 | 494 |
| TSACC | GARIN1B | Q96KD3 | 465 |
| TSACC | NUPR2 | A6NF83 | 457 |
| TSACC | CCDC54 | Q8NEL0 | 456 |
| TSACC | TM4SF18 | Q96CE8 | 450 |
| TSACC | TCEAL4 | Q96EI5 | 449 |
| TSACC | ANKRD7 | Q92527 | 448 |
| TSACC | ADAM32 | Q8TC27 | 448 |
IntAct
27 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TSACC | FOXP2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FOXP2 | TSACC | psi-mi:“MI:0915”(physical association) | 0.720 |
| TSACC | LIX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LIX1 | TSACC | psi-mi:“MI:0915”(physical association) | 0.560 |
| CRYAA | TSACC | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSACC | ATN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSACC | PAK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLF11 | TSACC | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSACC | NUP58 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DTNB | TSACC | psi-mi:“MI:0915”(physical association) | 0.370 |
| TSACC | KDM1A | psi-mi:“MI:0915”(physical association) | 0.370 |
| TSACC | FOXP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): TSACC (Two-hybrid), TSACC (Two-hybrid), TSACC (Two-hybrid), TSACC (Two-hybrid), TSACC (Affinity Capture-RNA), TSACC (Cross-Linking-MS (XL-MS)), TSACC (Affinity Capture-RNA), KDM1A (Two-hybrid)
ESM2 similar proteins: A6QL29, A7WNB2, B3NDY8, B4H957, B4IG10, B4J184, B4KZN6, B4MHR1, B4MXH8, B4QQE2, B5DRT7, B7Z073, O82286, P09513, P0C766, P13622, P14289, P14976, P17926, P19722, P29046, P29047, P33483, P36713, P68948, P68949, P68962, P68963, P75266, P80250, P97863, Q01047, Q09SZ8, Q0R5R0, Q1PD56, Q3E744, Q3SZX7, Q4R7E8, Q65YU9, Q6UY65
Diamond homologs: Q3T016, Q4R7E8, Q96A04, Q9DA44
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
943 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:156346740:T:TA | acceptor_gain | 1.0000 |
| 1:156346743:A:AG | acceptor_gain | 1.0000 |
| 1:156338152:A:AC | donor_gain | 0.9900 |
| 1:156338153:C:CC | donor_gain | 0.9900 |
| 1:156338153:CTGAG:C | donor_gain | 0.9900 |
| 1:156346744:C:G | acceptor_gain | 0.9900 |
| 1:156346748:C:A | acceptor_gain | 0.9900 |
| 1:156346751:T:A | acceptor_gain | 0.9900 |
| 1:156346763:T:TA | acceptor_gain | 0.9900 |
| 1:156346764:G:A | acceptor_gain | 0.9800 |
| 1:156338024:T:TA | donor_gain | 0.9600 |
| 1:156338132:T:TA | donor_gain | 0.9600 |
| 1:156344578:A:T | acceptor_gain | 0.9600 |
| 1:156346769:T:A | acceptor_gain | 0.9600 |
| 1:156338290:TAC:T | donor_gain | 0.9500 |
| 1:156338291:ACA:A | donor_gain | 0.9500 |
| 1:156338292:CAC:C | donor_gain | 0.9500 |
| 1:156344579:G:T | acceptor_gain | 0.9500 |
| 1:156346732:T:TA | acceptor_gain | 0.9500 |
| 1:156338153:CT:C | donor_gain | 0.9400 |
| 1:156338153:CTG:C | donor_gain | 0.9400 |
| 1:156338296:TCA:T | donor_gain | 0.9400 |
| 1:156338310:T:A | donor_gain | 0.9400 |
| 1:156344577:TA:T | acceptor_gain | 0.9400 |
| 1:156344578:A:AG | acceptor_gain | 0.9400 |
| 1:156344579:G:GG | acceptor_gain | 0.9400 |
| 1:156346766:AGTT:A | acceptor_gain | 0.9300 |
| 1:156346767:GT:G | acceptor_gain | 0.9300 |
| 1:156346767:GTT:G | acceptor_gain | 0.9300 |
| 1:156346767:GTTG:G | acceptor_gain | 0.9300 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000011592 (1:156343958 T>C), RS1000311668 (1:156344330 T>C), RS1000509068 (1:156344289 A>G), RS1000662458 (1:156343928 C>T), RS1000712347 (1:156338433 A>G), RS1000743269 (1:156338555 G>A,T), RS1001111989 (1:156342802 G>A,T), RS1001305265 (1:156336850 T>C), RS1001597568 (1:156338620 C>T), RS1002018688 (1:156340978 T>C), RS1002101043 (1:156344956 T>C), RS1002246123 (1:156341441 T>C), RS1002714337 (1:156335651 G>A), RS1002896083 (1:156346408 G>A), RS1003140286 (1:156339891 T>G)
Disease associations
OMIM: gene MIM:619679 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000582_7 | Mean corpuscular hemoglobin concentration | 3.000000e-09 |
| GCST001521_7 | Subcutaneous adipose tissue | 9.000000e-06 |
| GCST90000047_18 | Age at first sexual intercourse | 8.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004509 | hemoglobin measurement |
| EFO:0004528 | mean corpuscular hemoglobin concentration |
| EFO:0009749 | age at first sexual intercourse measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, increases expression | 1 |
| jinfukang | increases expression | 1 |
| Benzo(a)pyrene | affects expression | 1 |
| Cisplatin | increases expression | 1 |
| Lipopolysaccharides | affects cotreatment, increases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.